Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Unichem Laboratories Ltd. M&A Activity 2023

Aug 9, 2023

61109_rns_2023-08-09_a0886b54-ec2c-4dcd-bb17-72a906f7be13.pdf

M&A Activity

Open in viewer

Opens in your device viewer

ArihantCapîtal Generating Wealth

August 9, 2023

Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai - 400 001

Dear Sir,

Sub:Proposed open offer by Ipca Laboratories Limited (Acquirer) to the shareholders of Unichem Laboratories Limited (Target Company) in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 [SEBI SAST Regulations]

With reference to the captioned Open Offer, we wish to inform you that SEBI has, vide their letter dated August 8, 2023, issued their final observations on the Draft Letter of Offer filed with them enabling the Acquirer to proceed with the Open Offer.

The updated schedule of activities, including the offer opening date would be communicated in due course.

This is for your kind information and dissemination to the public.

Thanking you,

Yours faithfully, For Arihant Capital Markets Limited

Amol Kshirsagar Vice President – Merchant Banking

ARIHANT CAPITAL MARKETS LTD. MERCHANT BANKING DIVISION

Corporate Office : 1011, Building No. 10, Solitaire Corporate Park, Guru Hargovindji Road, Chakala, Andheri (East), Mumbai - 400 093 Tel.: 4225 4800 · Fax: 4225 4880 · E-mail: [email protected] · Website: www.arihantcapital.com Registered Office: 6, Lad Colony, Y. N. Road, Indore - 452 003 CIN: L67120MP1992PLC007182 ISO 9001:2015 CERTIFIED COMPANY